Gene Therapy
I started this column with a reference to Epstein’s book because, as I was reading BISG’s report, I was reminded that so much of the discussion in these columns is understandably addressed from the standpoint of the business and development interests of our industry. Epstein was looking at business and technology from a different place—the editorial and literary side, the product side.
Eugene G. Schwartz is editor at large for ForeWord Reviews, an industry observer and an occasional columnist for Book Business magazine. In an earlier career, he was in the printing business and held production management positions at Random House, Prentice-Hall/Goodyear and CRM Books/Psychology Today. A former PMA (IBPA) board member, he has headed his own publishing consultancy, Consortium House. He is also Co-Founder of Worthy Shorts Inc., a development stage online private press and publication service for professionals as well as an online back office publication service for publishers and associations. He is on the Publishing Business Conference and Expo Advisory Board.